COSMOS Pharmaceutical Corporation (TYO:3349)

COSMOS Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is June - May.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 30, 2025	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021
Cash & Equivalents	43,241	57,038	52,301	45,928	37,362	55,108
Cash & Short-Term Investments	43,241	57,038	52,301	45,928	37,362	55,108
Cash Growth	10.51%	9.06%	13.88%	22.93%	-32.20%	5.73%
Accounts Receivable	810	761	637	452	198	100
Other Receivables	-	11,479	11,562	9,769	8,379	6,519
Receivables	810	12,240	12,199	10,221	8,577	6,619
Inventory	99,777	92,323	86,173	77,479	66,363	60,549
Prepaid Expenses	-	2,857	2,568	2,429	2,189	1,944
Other Current Assets	20,270	1,164	1,092	1,028	980	905
Total Current Assets	164,098	165,622	154,333	137,085	115,471	125,125
Property, Plant & Equipment	350,064	331,125	295,798	259,464	225,286	195,131
Long-Term Investments	27,823	24,648	23,456	21,601	19,895	18,831
Other Intangible Assets	757	446	497	547	433	326
Long-Term Deferred Tax Assets	-	2,913	2,461	2,268	1,966	1,904
Other Long-Term Assets	2	1	1	2	1	1
Total Assets	542,744	524,755	476,546	420,967	363,052	341,318
Accounts Payable	186,357	177,125	179,549	161,852	139,224	133,041
Accrued Expenses	-	9,812	8,057	7,272	6,234	5,366
Short-Term Debt	-	-	4,581	2,741	1,387	1,486
Current Portion of Long-Term Debt	5,382	5,682	-	-	-	-
Current Portion of Leases	-	2,256	1,931	1,744	1,669	1,609
Current Income Taxes Payable	7,987	23,550	17,420	16,787	12,234	16,723
Other Current Liabilities	29,532	2,255	1,691	1,657	1,315	1,312
Total Current Liabilities	229,258	220,680	213,229	192,053	162,063	159,537
Long-Term Debt	34,719	37,202	23,385	10,018	3,000	4,088
Long-Term Leases	-	4,817	4,166	3,698	3,357	3,261
Pension & Post-Retirement Benefits	2,081	1,953	1,751	1,636	1,482	1,335
Other Long-Term Liabilities	7,555	2,640	2,574	2,491	2,644	2,519
Total Liabilities	273,613	267,292	245,105	209,896	172,546	170,740
Common Stock	4,178	4,178	4,178	4,178	4,178	4,178
Additional Paid-In Capital	5,101	5,101	5,101	4,610	4,610	4,610
Retained Earnings	259,986	248,309	222,284	202,485	181,954	162,065
Treasury Stock	-227	-227	-225	-242	-241	-238
Comprehensive Income & Other	93	102	103	40	5	-37
Shareholders' Equity	269,131	257,463	231,441	211,071	190,506	170,578
Total Liabilities & Equity	542,744	524,755	476,546	420,967	363,052	341,318
Total Debt	40,101	49,957	34,063	18,201	9,413	10,444
Net Cash (Debt)	3,140	7,081	18,238	27,727	27,949	44,664
Net Cash Growth	-76.66%	-61.17%	-34.22%	-0.79%	-37.42%	11.66%
Net Cash Per Share	39.62	89.34	230.16	350.10	352.90	563.95
Filing Date Shares Outstanding	79.26	79.26	79.26	79.2	79.2	79.2
Total Common Shares Outstanding	79.26	79.26	79.26	79.2	79.2	79.2
Working Capital	-65,160	-55,058	-58,896	-54,968	-46,592	-34,412
Book Value Per Share	3395.66	3248.45	2920.11	2665.11	2405.44	2153.81
Tangible Book Value	268,374	257,017	230,944	210,524	190,073	170,252
Tangible Book Value Per Share	3386.11	3242.82	2913.84	2658.21	2399.98	2149.70

Updated Nov 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.